Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02100163 · ClinicalTrials.gov registry record · NA

Virtual Reality Pain Control Orthopedic Trauma

A NA study, sponsored by National Institute of General Medical Sciences (NIGMS).

Completed
Registry status
NA
Development phase
211
Enrollment target

NCT02100163 is a NA study that has completed, run by National Institute of General Medical Sciences (NIGMS). The registered enrollment target is 211 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02100163, a NA study, has completed, sponsored by National Institute of General Medical Sciences (NIGMS).

COMPLETED
Registry status
NA
Development phase
211 participants
Enrollment target

Study Summary

The treatment of postoperative pain after severe trauma is poorly understood, and it can lead to chronic pain, opiate drug addiction and elevated health care costs. The proposed project will be a randomized controlled trial to evaluate an innovative methodology for delivering clinical hypnosis (virtual reality hypnosis) for pain control as well as a more time-honored delivery system that uses audio recordings. The goal will be to reduce postoperative pain in a sample of patients hospitalized for the care of severe orthopedic trauma and other types trauma. This proposal will test innovative and low-risk approaches to reducing postoperative trauma pain that are designed to reduce pain, anxiety and other complications after surgery. The findings have the potential not only to reduce pain and suffering in patients who have suffered severe trauma but could be applicable to the millions of people who have surgery every year. Reducing addictive opiate-based medication and health care costs are both potential outcomes from this project.

Interventions

  • OTHER Standard treatment
  • BEHAVIORAL Virtual Reality Hypnosis
  • BEHAVIORAL Audio Hypnosis

Trial Details

FieldValue
Enrollment Target 211 participants
Start Date 2014-03
Est. Completion 2018-06-24
Phase NA

What the Registry Record Tells You About NCT02100163

The ClinicalTrials.gov registry entry for NCT02100163 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 211 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is National Institute of General Medical Sciences (NIGMS), which has 14 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 3 interventions - of which Standard treatment is the first listed.

NCT02100163 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT02100163 about?

NCT02100163 is a clinical study titled "Virtual Reality Pain Control Orthopedic Trauma". The treatment of postoperative pain after severe trauma is poorly understood, and it can lead to chronic pain, opiate drug addiction and elevated health care costs. The proposed project will be a randomized controlled trial to evaluate an innovative methodology for delivering clinical hypnosis (virt...

What is the current status of trial NCT02100163?

This trial is currently completed. It is a NA study. The enrollment target is 211 participants. The study started on 2014-03. Estimated completion is 2018-06-24.

What interventions are being tested in trial NCT02100163?

The interventions under investigation include: Standard treatment (OTHER), Virtual Reality Hypnosis (BEHAVIORAL), Audio Hypnosis (BEHAVIORAL).

Who is sponsoring clinical trial NCT02100163?

This trial is sponsored by National Institute of General Medical Sciences (NIGMS), which has 14 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.